BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Woolbright BL, Jaeschke H. Alcoholic Hepatitis: Lost in Translation. J Clin Transl Hepatol 2018;6:89-96. [PMID: 29577035 DOI: 10.14218/JCTH.2017.00054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Vatsalya V, Cave MC, Kong M, Gobejishvili L, Falkner KC, Craycroft J, Mitchell M, Szabo G, McCullough A, Dasarathy S, Radaeva S, Barton B, McClain CJ. Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2020;18:2046-54. [PMID: 31811953 DOI: 10.1016/j.cgh.2019.11.050] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
2 Philips CA, Rajesh S, George T, Ahamed R, Kumbar S, Augustine P. Outcomes and Toxicology of Herbal Drugs in Alcoholic Hepatitis - A Single Center Experience from India.J Clin Transl Hepatol. 2019;7:329-340. [PMID: 31915602 DOI: 10.14218/JCTH.2019.00043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Woolbright BL, Jaeschke H. Is Keratin-18 only a Marker of Cell Death in Acute-On-Chronic Liver Failure? J Lab Precis Med 2018;3:26. [PMID: 29928749 DOI: 10.21037/jlpm.2018.03.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Sheriff L, Khan RS, Saborano R, Wilkin R, Luu NT, Gunther UL, Hubscher SG, Newsome PN, Lalor PF. Alcoholic hepatitis and metabolic disturbance in female mice: a more tractable model than Nrf2 -/- animals. Dis Model Mech 2020;13:dmm046383. [PMID: 33067186 DOI: 10.1242/dmm.046383] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Singal AK, Bailey SM. Cellular Abnormalities and Emerging Biomarkers in Alcohol-Associated Liver Disease. Gene Expr 2018;19:49-60. [PMID: 30086817 DOI: 10.3727/105221618X15325235888914] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
6 Teschke R. Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects. Biomedicines 2018;6:E106. [PMID: 30424581 DOI: 10.3390/biomedicines6040106] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 11.5] [Reference Citation Analysis]
7 Song Y, Kim S, Heo J, Shum D, Lee SY, Lee M, Kim AR, Seo HR. Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model. Sci Rep 2021;11:10931. [PMID: 34035369 DOI: 10.1038/s41598-021-90263-x] [Reference Citation Analysis]
8 Weiskirchen R, Weiskirchen S, Tacke F. Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000Res 2018;7:F1000 Faculty Rev-921. [PMID: 30002817 DOI: 10.12688/f1000research.14841.1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
9 Woolbright BL, Harris RA. PDK2: An Underappreciated Regulator of Liver Metabolism. Livers 2021;1:82-97. [DOI: 10.3390/livers1020008] [Reference Citation Analysis]